Skip to main content
Hua Huang, MD, Oncology, Flushing, NY, New York-Presbyterian Queens

HuaHuangMDPhD

Oncology Flushing, NY

Hematologic Oncology

Physician

Dr. Huang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Huang's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Hematology and Medical Oncology, 2004 - 2006
  • One Brooklyn Health System/Interfaith Medical Center
    One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Shanghai Medical University
    Shanghai Medical UniversityClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - Present
  • NY State Medical License
    NY State Medical License 2002 - 2025
  • CO State Medical License
    CO State Medical License 2002 - 2005
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Authored Content

  • Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric CancerAugust 2020
  • Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric CancerAugust 2020
  • Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric CancerAugust 2020

Press Mentions

  • GATA2 Regulates Mast Cell Identity and Responsiveness to Antigenic Stimulation by Promoting Chromatin Remodeling at Super-Enhancers
    GATA2 Regulates Mast Cell Identity and Responsiveness to Antigenic Stimulation by Promoting Chromatin Remodeling at Super-EnhancersJanuary 21st, 2021
  • An Overview of Genetic Mutations and Epigenetic Signatures in the Course of Pancreatic Cancer Progression
    An Overview of Genetic Mutations and Epigenetic Signatures in the Course of Pancreatic Cancer ProgressionJanuary 10th, 2021
  • Preclinical Models of Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities in the Era of Precision Medicine
    Preclinical Models of Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities in the Era of Precision MedicineJanuary 5th, 2021
  • Join now to see all

Hospital Affiliations